A Pilot Study Evaluating the Effect of Intravitreal Fluocinolone Acetonide (0.19mg) in Patients with Retinitis Pigmentosa - Iluvien for IRD

Moorfields Eye Hospital0 个研究点目标入组 1 人开始时间: 2016年7月5日最近更新: 2019年12月16日

适应症

试验速览

暂无简介。

•Adult patients with retinitis pigmentosa and signs of intraocular inflammation (vitreous cells, cataract, epiretinal membrane, intraretinal oedema, clinically significant migration of pigment cells into the retina??).
•Are the trial subjects under 18? no
•Number of subjects for this age range: 0
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range 15
•F.1.3 Elderly (>=65 years) yes
•F.1.3.1 Number of subjects for this age range 5

•1. Patients in whom Fluocinolone Acetonide is contraindicated (prior infectious eye disease, glaucoma or ?steroid induced ocular hypertension). ?
•?2.? Patients with a clinically apparent asymmetric expression of their retinopathy (as determined by an experienced retina physician).?
•?3.? High ametropia (greater than ±6D) to avoid complications of cataract surgery should it be ?necessary.?
•?4.? Patients with planned intraocular surgery within the study period.?
•5. Patients with dense cataract precluding adequate fundus imaging.
•6. Female patients who are pregnant or breastfeeding. Female patients of child-bearing age should ensure an adequate contraceptive measure is used.
•7. Patients known to require other forms of systemic immunosuppression within the study period.

发起方